Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Seres Therapeutics, Inc. (MCRB)

1.9800 -0.1100 (-5.26%)
At close: November 6 at 4:00:01 PM EST
2.0101 +0.0301 (+1.52%)
After hours: November 6 at 4:06:55 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
789
789
0
0
0
Cost of Revenue
592
6,544
3,532
0
0
Gross Profit
197
-5,755
-3,532
0
0
Operating Expense
66,394
88,216
117,783
195,097
179,914
Operating Income
-66,197
-93,971
-121,315
-195,097
-179,914
Net Non Operating Interest Income Expense
1,097
2,227
3,967
4,833
-2,962
Other Income Expense
18,147
97,440
-8,423
134
-705
Pretax Income
-46,953
5,696
-125,771
-190,130
-183,581
Net Income Common Stockholders
-46,953
5,696
136
-113,724
-250,157
Diluted NI Available to Com Stockholders
-46,953
5,696
136
-113,724
-250,157
Basic EPS
-5.01
0.64
0.00
-17.77
-46.20
Diluted EPS
-5.01
0.64
0.00
-17.77
-46.20
Basic Average Shares
9,630.9840
8,858.9750
7,769.9100
6,400.3390
5,403.8520
Diluted Average Shares
9,634.7160
8,869.7420
7,769.9100
6,400.3390
5,403.8520
Total Operating Income as Reported
-77,709
-93,971
-121,315
-195,097
-179,914
Total Expenses
66,986
94,760
121,315
195,097
179,914
Net Income from Continuing & Discontinued Operation
-46,953
5,696
136
-113,724
-250,157
Normalized Income
-61,538
-74,989
-131,455
-190,130
-183,581
Interest Income
1,097
2,227
3,967
7,301
3,058
Interest Expense
0
0
0
2,468
6,020
Net Interest Income
1,097
2,227
3,967
4,833
-2,962
EBIT
33,470
5,696
-125,771
-187,662
-177,561
EBITDA
36,356
9,829
-120,303
-181,419
-170,932
Reconciled Cost of Revenue
592
6,544
3,532
0
0
Reconciled Depreciation
2,886
4,133
5,468
6,243
6,629
Net Income from Continuing Operation Net Minority Interest
-46,953
5,696
-125,771
-190,130
-183,581
Total Unusual Items Excluding Goodwill
14,585
80,685
5,684
0
0
Total Unusual Items
14,585
80,685
5,684
0
0
Normalized EBITDA
21,771
-70,856
-125,987
-181,419
-170,932
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 6/26/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: